Sirolimus and islet transplants

被引：6

作者：

Hering, BJ ^{[1
]}

Wijkstrom, M ^{[1
]}

机构：

[1] Univ Minnesota, Dept Surg, Diabet Inst Immunol & Transplantat, Minneapolis, MN 55455 USA

来源：

TRANSPLANTATION PROCEEDINGS | 2003年 / 35卷 / 3A期

关键词：

D O I：

10.1016/S0041-1345(03)00228-8

中图分类号：

R392 [医学免疫学]; Q939.91 [免疫学];

学科分类号：

100102 ;

摘要：

引用

页码：187S / 190S

页数：4

共 35 条

[1]

ABINOVITCH A, 2002, DIABETES, V51, P638

[2] Calcineurin inhibitor-free CD28 blockade-based protocol protects allogeneic islets in nonhuman primates [J].

Adams, AB ;

Shirasugi, N ;

Durham, MM ;

Strobert, E ;

Anderson, D ;

Rees, P ;

Cowan, S ;

Xu, HY ;

Blinder, Y ;

Cheung, M ;

Hollenbaugh, D ;

Kenyon, NS ;

Pearson, TC ;

Larsen, CP .

DIABETES, 2002, 51 (02) :265-270

[3]

ALEJANDRO R, 2002, TRANSPLANTATION S3, V2, P227

[4]

BAEDER WL, 1992, CLIN EXP IMMUNOL, V89, P174

[5]

BOBBIO SA, 1993, TRANSPLANT P, V25, P2745

[6] A humanized anti-human CD154 monoclonal antibody blocks CD154-CD40 mediated human B cell activation [J].

Brams, P ;

Black, A ;

Padlan, EA ;

Hariharan, K ;

Leonard, J ;

Chambers-Slater, K ;

Noelle, RJ ;

Newman, R .

INTERNATIONAL IMMUNOPHARMACOLOGY, 2001, 1 (02) :277-294

[7]

DUMONT FJ, 1990, J IMMUNOL, V144, P1418

[8] THE EFFICACY AND TOXICITY OF RAPAMYCIN IN MURINE ISLET TRANSPLANTATION - IN-VITRO AND IN-VIVO STUDIES [J].

FABIAN, MC ;

LAKEY, JRT ;

RAJOTTE, RV ;

KNETEMAN, NM .

TRANSPLANTATION, 1993, 56 (05) :1137-1142

[9]

HERING BJ, 2001, AM J TRANSPLANT S1, V1, P180

[10] Pancreatic islet transplantation using the nonhuman primate (rhesus) model predicts that the portal vein is superior to the celiac artery as the islet infusion site [J].

Hirshberg, B ;

Montgomery, S ;

Wysoki, MG ;

Xu, H ;

Tadaki, D ;

Lee, J ;

Hines, K ;

Gaglia, J ;

Patterson, N ;

Leconte, J ;

Hale, D ;

Chang, R ;

Kirk, AD ;

Harlan, DM .

DIABETES, 2002, 51 (07) :2135-2140

← 1 2 3 4 →